S
Sera Economics
← US Companies

REGENERON PHARMACEUTICALS, INC.

REGN · Nasdaq · CIK 0000872589

SIC 2834

Pharmaceutical Preparations

Category

Chemicals

Entity

operating

Incorp.

NY

Fiscal Y/E

1231

Source: SEC EDGAR · All filings on SEC →

Investment Indicators

ROE

14.41%

ROA

11.11%

D/E Ratio

0.30

Current Ratio

4.13

Operating Margin

60.93%

Net Margin

76.72%

Book Value/Share

$344.65

Financial Statements

In USD millions (per-share figures shown directly) · Financials as of: 2026-02-04

Income Statement

FY20252024202320222021
Operating Income3,5783,9914,0474,7398,947
Net Income4,5054,4133,9544,3388,075
EPS (Basic)43.0740.9037.0540.5176.40
EPS (Diluted)41.4838.3434.7738.2271.97

Balance Sheet

FY20252024202320222021
Total Assets40,55937,75933,08029,21525,435
Current Assets18,02218,66119,47915,88414,015
Cash & Equivalents3,1182,4882,7303,1062,886
Total Liabilities9,3028,4067,1076,5516,666
Current Liabilities4,3683,9443,4233,1413,933
Long-term Debt1,9861,9841,9831,9811,980
Total Equity31,25729,35425,97322,66418,769

Cash Flow

FY20252024202320222021
Operating CF4,9794,4214,5945,0157,081
Investing CF-629-2,468-3,185-3,785-5,385
Financing CF-3,715-2,201-1,790-1,009-1,006
Dividends Paid370

📄 SEC Filings

Other filings (75)
4

Insider Transaction

PRIMARY DOCUMENT

2026-05-04

Open →

SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X02/primary_doc.xml

2026-04-30

Open →

ARS

ARS

ARS

2026-04-24

Open →

DEFA14A

DEFA14A

DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

2026-04-24

Open →

4

Insider Transaction

OWNERSHIP DOCUMENT

2026-04-03

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X02/primary_doc.xml

2026-03-27

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-03-03

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-23

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-19

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-11

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-11

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-09

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-09

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-08

Open →

144

144

xsl144X01/primary_doc.xml

2026-01-07

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-05

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-05

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-31

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-11

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-11

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-11

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-11

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-11

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-09

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-09

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-09

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-09

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-09

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-09

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-11-24

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-11-24

Open →

144

144

xsl144X01/primary_doc.xml

2025-11-20

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-11-10

Open →

144

144

xsl144X01/primary_doc.xml

2025-11-07

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-10-31

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-10-31

Open →

144

144

xsl144X01/primary_doc.xml

2025-10-29

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X01/primary_doc.xml

2025-08-06

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X01/primary_doc.xml

2025-06-05

Open →

ARS

ARS

ARS

2025-04-29

Open →

DEFA14A

DEFA14A

DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

2025-04-29

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X01/primary_doc.xml

2025-04-22

Open →

UPLOAD

UPLOAD

filename1.pdf

2025-04-17

Open →

PRE 14A

PRE 14A

PRELIMINARY PROXY STATEMENT

2025-04-07

Open →

CORRESP

CORRESP

filename1.htm

2025-04-03

Open →

UPLOAD

UPLOAD

filename1.pdf

2025-03-21

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X01/primary_doc.xml

2025-02-12

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-01-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-01-03

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2024-12-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2024-12-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2024-12-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2024-12-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2024-12-18

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2024-12-18

Open →

REGENERON PHARMACEUTICALS, INC. (REGN) — Pharmaceutical Preparations | Sera Economics